Stromal-epithelial interactions in early neoplasia

Cancer Biomarkers

Volumn 9, Issue 1-6, 2011, Pages 141-155

  Liu, Alvin Y ^a   Pascal, Laura E ^a,c   Vêncio, Ricardo Z ^b   Vêncio, Eneida F ^a,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

CD26 + cancer cells; CD90 + cancer associated stromal cells; cell type transcriptomes; cell cell interaction; Gleason patterns; in vitro co culture; intercellular signaling molecules; mRNA and miRNA expression changes; NCCIT embryonal carcinoma cells; Prostate cancer; stromal induction of stem cells

Indexed keywords

MESSENGER RNA; MICRORNA;

ARTICLE; BLADDER; CELL DIFFERENTIATION; CELL INTERACTION; CELL LINEAGE; CELL STRUCTURE; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SOMATIC MUTATION; STEM CELL; STROMA CELL;

ANIMALS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER;

EID: 82955193349     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2011-0174     Document Type: Article

References (64)

1. A. Y. Liu and L. D. True, Characterization of prostate cell types y CD cell surface molecules, Am J Pathol 160 (2002), 37-43.
2. A. J. Oudes, D. S. Campbell, C. M. Sorensen, L. S. Walashek, L. D. True and A. Y. Liu, Transcriptomes of human prostate cells, BMC Genomics 7 (2006), 92.
3. L. E. Pascal. Y. A. Goo, R. Z. N. Vêncio, L. S. Page, A. A. Chambers, E. S. Liebeskind, T. K. Takayama, L. D. True, and A. Y. Liu, Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes. BMC Cancer 9 (2009), 317.
4. L. E. Pascal, R. Z. N. Vêncio, L. S. Page, E. S. Liebeskind, C. P. Shadle, P. Troisch, B. Marzolf, L. D. True, L. E. Hood and A. Y. Liu, Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes, BMC Cancer 9 (2009), 452.
5. A. Y. Liu, Differential expression of cell surface molecules in prostate cancer cells, Cancer Res 60 (2000), 3429-3434.
6. A. Y. Liu, M. P. Roudier and L. D. True, Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile, Am J Pathol 165 (2004), 1543-1556.
7. G. R. Cunha, Mesenchymal-epithelial interactions: past, present, and future, Differentiation 76 (2008), 578-586.
8. S. Aboseif, A. El-Sakka, P. Young and G. Cunha, Mesenchymal reprogramming of adult human epithelial differentiation, Differentiation 65 (1999), 113-118.
9. A. Y. Liu, L. LaTray and G. van den Engh, Changes in cell surface molecules associated with in vitro culture of prostatic stromal cells, Prostate 45 (2000), 303-312.
10. Y. A. Goo, D. R. Goodlett, L. E. Pascal, K. D. Worthington, R. L. Vessella, L. D. True and A. Y. Liu, Stromal mesenchyme cell genes of the human prostate and bladder, BMC Urol 5 (2005), 17.
11. Y. A. Goo, A. Y. Liu, S. Ryu, S. A. Shaffer, L. Malmström, L. Page, L. T. Nguyen, C. E. Doneanu and D. R. Goodlett, Identification of secreted glycoproteins of human prostate and bladder stromal cells by comparative quantitative proteomics, Prostate 69 (2009), 49-61.
12. M. Ashburner, C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, M. A. Harris, D. P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. C. Matese, J. E. Richardson, M. Ringwald, G. M. Rubin and G. Sherlock, Gene ontology: tool for the unification of biology. The Gene Ontology Consortium, Nat Genet 25 (2000), 25-29.
13. A. Vaalasti, I. Linnoila and A. Hervonen, Immunohistochemical demonstration of VIP, [Met5]- and [Leu5]-enkephalin immunoreactive nerve fibres in the human prostate and seminal esicles, Histochemistry 66 (1980), 89-98.
14. H. Rosen, A. Krichevsky, R. D. Polakiewicz, S. Benzakine and Z. Bar-Shavit, Developmental regulation of proenkephalin gene expression in osteoblasts, Mol Endocrinol 9 (1995), 1621-1631.
15. A. Y. Liu, L. D. True, L. LaTray, P. S. Nelson, W. J. Ellis, R. L. Vessella, P. H. Lange, L. Hood and G. van den Engh, Cell-cell interaction in prostate gene regulation and cytodifferentiation, Proc Natl Acad Sci 94 (1997), 10705-10710.
16. A. Y. Liu, H. Zhang, C. M. Sorensen and D. L. Diamond, Analysis of prostate cancer by proteomics using tissue specimens, J Urol 173 (2005), 73-78.
17. - subpopulations exhibit distinct phenotypes, Eur J Immunol 32 (2002), 477-485.
18. L. Koumas, T. J. Smith, S. Feldon, N. Blumberg and R. P. Phipps, Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes, Am J Pathol 163 (2003), 1291-1300.
19. Y. Zhou, J. S. Hagood and J. E. Murphy-Ullrich, Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli, Am J Pathol 165 (2004), 659-669.
20. J. A. Tuxhorn, G. E. Ayala, M. J. Smith, V. C. Smith, T. D. Dang and D. R. Rowley, Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling, Clin Cancer Res 8 (2002), 2912-2923.
21. C. Wissmann, P. J. Wild, S. Kaiser, S. Roepcke, R. Stoehr, M. Woenckhaus, G. Kristiansen, J. C. Hsieh, F. Hofstaedter, A. Hartmann, R. Knuechel, A. Rosenthal and C. Pilarsky, WIF1, a component of theWnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer, J Pathol 201 (2003), 204-212.
22. C. Sonnenschein and A. Soto, Theories of carcinogenesis: an emerging perspective, Semin Cancer Biol 18 (2008), 372-377.
23. M. H. Barcellos-Hoff and S. A. Ravani, Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells, Cancer Res 60 (2000), 1254-1260.
24. W. Qiu, M. Hu, A. Sridhar, K. Opeskin, S. Fox, M. Shipitsin, M. Trivett, E. R. Thompson, M. Ramakrishna, K. L. Gorringe, K. Polyak, I. Haviv and I. G. Campbell, No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas, Nat Genet 40 (2008), 650-655.
25. E. M. Lange, J. L. Beebe-Dimmer, A. M. Ray, K. A. Zuhlke, J. Ellis, Y. Wang, S. Walters and K. A. Cooney, Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan prostate cancer genetics project: suggestive evidence for linkage at 16q23, Prostate 69 (2009), 385-391.
26. M. Hu, J. Yao, L. Cai, K. E. Bachman, F. van den Brule, V. Velculescu and K. Polyak, Distinct epigenetic changes in the stromal cells of breast cancers, Nat Genet 37 (2005), 899-905.
27. K. Fukino, L. Shen, S. Matsumoto, C. D. Morrison, G. L. Mutter and C. Eng, Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets, Cancer Res 64 (2004), 7231-7236.
28. A. Orimo, P. B. Gupta, D. C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V. J. Carey, A. L. Richardson and R. A. Weinberg, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell 121 (2005), 335-348.
29. R. Hill, Y. Song, R. D. Cardiff and T. Van Dyke, Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis, Cell 123 (2005), 1001-1011.
30. I. F. San Francisco, W. C. DeWolf, D. M. Peehl and A. F. Olumi, Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts, Int J Cancer 112 (2004), 213-218.
31. A. F. Olumi, G. D. Grossfeld, S. W. Hayward, P. R. Carroll, T. D. Tlsty and G. R. Cunha, Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium, Cancer Res 59 (1999), 5002-5011.
32. Y. Wang, D. Sudilovsky, B. Zhang, P. C. Haughney, M. A. Rosen, D. S. Wu, T. J. Cunha, R. Dahiya, G. R. Cunha and S. W. Hayward, A human prostatic epithelial model of hormonal carcinogenesis, Cancer Res 61 (2001), 6064-6072.
33. R. E. Sobel and M. D. Sadar, Cell lines used in prostate cancer research: a compendium of old and new lines - part 1, J Urol 173 (2005), 342-359.
34. M. Kawada, H. Inoue, T. Masuda and D. Ikeda, Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer, Cancer Res 66 (2006), 4419-4425.
35. L. E. Pascal, A. J. Oudes, T. W. Petersen, Y. A. Goo, L. S. Walashek, L. D. True and A. Y. Liu, Molecular and cellular characterization of ABCG2 in the prostate, BMC Urol 7 (2007), 6.
36. C. B. Ware, A. M. Nelson and C. A. Blau, A comparison of NIH-approved human ES cell lines, Stem Cells 24 (2006), 2677-2684.
37. R. A. Taylor, P. A. Cowin, G. R. Cunha, M. Pera, A. O. Trounson, J. Pedersen and G. P. Risbridger, Formation of human prostate tissue from embryonic stem cells, Nat Methods 3 (2006), 179-181.
38. S. Oottamasathien, Y. Wang, K. Williams, O. E. Franco, M. L. Wills, J. C. Thomas, K. Saba, A. Sharif-Afshar, J. H. Makari, N. A. Bhowmick, R. T. DeMarco, S. Hipkens, M. Magnuson, J. W. Brock, S. W. Hayward, J. C. Pope and R. J. Matusik, Directed differentiation of embryonic stem cells into bladder tissue, Dev Biol 304 (2007), 556-566.
39. P. W. Andrews, M. M. Matin, A. R. Bahrami, I. Damjanov, P. Gokhale and J. S. Draper, Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin, Biochem Soc Trans 33 (2005), 1526-1530.
40. M. M. Matin, J. R. Walsh, P. J. Gokhale, J. S. Draper, A. R. Bahrami, I. Morton, H. D. Moore and P. W. Andrews, Specific knockdown of Oct4 and β2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells, Stem Cells 22 (2004), 659-668.
41. I. Damjanov, D. Solter and N. Skreb, Enzyme histochemistry of experimental embryo-derived teratocarcinomas, Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 76 (1971), 249-256.
42. J. M. Sperger, X. Chen, J. S. Draper, J. E. Antosiewicz, C. H. Chon, S. B. Jones, J. D. Brooks, P. W. Andrews, P. D. Brown and J. A. Thomson, Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors, Proc Natl Acad Sci 100 (2003), 13350-13355.
43. S. Teshima, Y. Shimosato, S. Hirohashi, Y. Tome, I. Hayashi, H. Kanazawa and T. Kakizoe, Four new human germ cell tumor cell lines, Lab Invest 59 (1988), 328-336.
44. B. Greber, H. Lehrach and J. Adjaye, Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal, BMC Dev Biol 7 (2007), 46.
45. M. M. Mostert, M. van de Pol, J. van Echten, D. OldeWeghuis, A. Geurts van Kessel, J. W. Oosterhuis and L. H. Looijenga, Fluorescence in situ hybridization-based approaches for detection of 12p overrepresentation, in particular i(12p), in cell lines of human testicular germ cell tumors of adults, Cancer Genet Cytogenet 87 (1996), 95-102.
46. C. Rosenberg, R. J. van Gurp, E. Geelen, J. W. Oosterhuis and L. H. Looijenga, Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas, Oncogene 19 (2000), 5858-5862.
47. J. S. Draper, K. Smith, P. Gokhale, H. D. Moore, E. Maltby, J. Johnson, L. Meisner, T. P. Zwaka, J. A. Thomson and P. W. Andrews, Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells, Nat Biotechnol 22 (2004), 53-54.
48. M. M. Mitalipova, R. R. Rao, D. M. Hoyer, J. A. Johnson, L. F. Meisner, K. L. Jones, S. Dalton and S. L. Stice, Preserving the genetic integrity of human embryonic stem cells, Nat Biotechnol 23 (2005), 19-20.
49. C. C. Shih, S. J. Forman, P. Chu and M. Slovak, Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice, Stem Cells Dev 16 (2007), 893-902.
50. F. Cao, K. E. van der Bogt, A. Sadrzadeh, X. Xie, A. Y. Sheikh, H. Wang, A. J. Connolly, R. C. Robbins and J. C. Wu, Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation, Stem Cells Dev 16 (2007), 883-891.
51. I. Damjanov, B. Horvat and Z. Gibas, Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT, Lab Invest 68 (1993), 220-232.
52. L. E. Pascal, R. Z. N. Vêncio, Y. A. Goo, L. S. Page, C. P. Shadle and A. Y. Liu, Temporal expression profiling of the effects of secreted factors from prostate stromal cells on embryonal carcinoma stem cells, Prostate 69 (2009), 1353-1365.
53. L. E. Pascal, L. D. True, D. S. Campbell, E. W. Deutsch, M. Risk, I. M. Coleman, L. J. Eichner, P. S. Nelson and A. Y. Liu, Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate, BMC Genomics 9 (2008), 246.
54. C. K. Taranger, A. Noer, A. L. Sørensen, A. Håkelien, A. C. Boquest and P. Collas, Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprograming by extracts of carcinoma and embryonic stem cells, Mol Biol Cell 16 (2005), 5719-5735.
55. E. F. Vêncio, L. E. Pascal, L. S. Page, G. Denyer, A. J. Wang, H. Ruohola-Baker, S. Zhang, K. Wang, D. J. Galas and A. Y. Liu, Embryonic carcinoma cell induction of miRNA and mRNA changes in co-cultured prostate stromal fibromuscular cells, J Cell Physiol (2010) Epub, (Oct).
56. W. C. S. Cho, OncomiRs: the discovery and progress of microRNAs in cancers, Mol Cancer 6 (2007), 60.
57. T. Papagiannakopoulos and K. S. Kosik, MicroRNAs: regulators of oncogenesis and stemness, BMC Medicine 6 (2008), 15.
58. X. Shi, C. G. Tepper and R. W. deVereWhite, MicroRNAs and prostate cancer, J Cell Mol Medicine 12 (2008), 1456-1465.
59. M. S. Joesting, S. Perrin, B. Elenbaas, S. E. Fawell, J. S. Rubin, O. E. Franco, S. W. Hayward, G. R. Cunha and P. C. Marker, Identification of SFRP1 as a candidate mediator of stromal-toepithelial signaling in prostate cancer, Cancer Res 65 (2005), 10423-10430.
60. X. Cai, C. H. Hagedorn and B. R. Cullen, Human mciroRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs, RNA 10 (2004), 1957-1966.
61. J. A. Chan, A. M. Krichevsky and K. S. Kosik, MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells, Cancer Res 65 (2005), 6029-6033.
62. R. van der Voort, T. E. Taher, P. W. Derksen, M. Spaargaren, R. Van der Neut and S. T. Pals, The hepatocyte growth factor/ Met pathway in development, tumorigenesis, and B-cell differentiation, Adv Cancer Res 79 (2000), 39-90.
63. A. Fleischmann, T. Schlomm, H, Huland, J. Köllermann, P. Simon, M. Mirlacher, G. Salomon, F. H. K. Chun, T. Steuber, R. Simon, G. Sauter, M. Graefen and A. Erbersdobler, Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients, Clin Cancer Res 23 (2008), 7838-7842.
64. A. Y. Liu, K. D. Brubaker, Y. A. Goo, J. E. Quinn, S. Kral, C. M. Sorensen, R. L. Vessella, A. S. Belldegrun and L. E. Hood, Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines, Prostate 60 (2004), 98-108.